The global healthcare reimbursement market size is calculated at USD 30.6 billion in 2025 and is forecasted to reach around USD 139.09 billion by 2034, accelerating at a CAGR of 18.32% from 2025 to 2034. The North America healthcare reimbursement market size surpassed USD 13.96 billion in 2024 and is expanding at a CAGR of 18.43% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Healthcare Reimbursement Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Healthcare Reimbursement Market, by Claim Type
8.1.1. Fully Paid
8.1.1.1. Market Revenue and Forecast
8.1.2. Underpaid
8.1.2.1. Market Revenue and Forecast
9.1. Healthcare Reimbursement Market, by Payers
9.1.1. Private
9.1.1.1. Market Revenue and Forecast
9.1.2. Public
9.1.2.1. Market Revenue and Forecast
10.1. Healthcare Reimbursement Market, by Service Provider
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Diagnostic Labs
10.1.2.1. Market Revenue and Forecast
10.1.3. Physician Office
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Claim
11.1.2. Market Revenue and Forecast, by Payers
11.1.3. Market Revenue and Forecast, by Service Provider
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Claim
11.1.4.2. Market Revenue and Forecast, by Payers
11.1.4.3. Market Revenue and Forecast, by Service Provider
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Claim
11.1.5.2. Market Revenue and Forecast, by Payers
11.1.5.3. Market Revenue and Forecast, by Service Provider
11.2. Europe
11.2.1. Market Revenue and Forecast, by Claim
11.2.2. Market Revenue and Forecast, by Payers
11.2.3. Market Revenue and Forecast, by Service Provider
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Claim
11.2.4.2. Market Revenue and Forecast, by Payers
11.2.4.3. Market Revenue and Forecast, by Service Provider
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Claim
11.2.5.2. Market Revenue and Forecast, by Payers
11.2.5.3. Market Revenue and Forecast, by Service Provider
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Claim
11.2.6.2. Market Revenue and Forecast, by Payers
11.2.6.3. Market Revenue and Forecast, by Service Provider
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Claim
11.2.7.2. Market Revenue and Forecast, by Payers
11.2.7.3. Market Revenue and Forecast, by Service Provider
11.3. APAC
11.3.1. Market Revenue and Forecast, by Claim
11.3.2. Market Revenue and Forecast, by Payers
11.3.3. Market Revenue and Forecast, by Service Provider
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Claim
11.3.4.2. Market Revenue and Forecast, by Payers
11.3.4.3. Market Revenue and Forecast, by Service Provider
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Claim
11.3.5.2. Market Revenue and Forecast, by Payers
11.3.5.3. Market Revenue and Forecast, by Service Provider
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Claim
11.3.6.2. Market Revenue and Forecast, by Payers
11.3.6.3. Market Revenue and Forecast, by Service Provider
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Claim
11.3.7.2. Market Revenue and Forecast, by Payers
11.3.7.3. Market Revenue and Forecast, by Service Provider
11.4. MEA
11.4.1. Market Revenue and Forecast, by Claim
11.4.2. Market Revenue and Forecast, by Payers
11.4.3. Market Revenue and Forecast, by Service Provider
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Claim
11.4.4.2. Market Revenue and Forecast, by Payers
11.4.4.3. Market Revenue and Forecast, by Service Provider
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Claim
11.4.5.2. Market Revenue and Forecast, by Payers
11.4.5.3. Market Revenue and Forecast, by Service Provider
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Claim
11.4.6.2. Market Revenue and Forecast, by Payers
11.4.6.3. Market Revenue and Forecast, by Service Provider
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Claim
11.4.7.2. Market Revenue and Forecast, by Payers
11.4.7.3. Market Revenue and Forecast, by Service Provider
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Claim
11.5.2. Market Revenue and Forecast, by Payers
11.5.3. Market Revenue and Forecast, by Service Provider
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Claim
11.5.4.2. Market Revenue and Forecast, by Payers
11.5.4.3. Market Revenue and Forecast, by Service Provider
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Claim
11.5.5.2. Market Revenue and Forecast, by Payers
11.5.5.3. Market Revenue and Forecast, by Service Provider
12.1. UnitedHealth Group
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Aviva
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Allianz
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. CVS Overall health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. BNP Paribas
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aetna
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nippon Life Insurance policies
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. WellCare Health Ideas
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agile Health Insurance
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Violet Cross Blue Cover Association.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample